{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:13:31Z","timestamp":1775481211932,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Egyptian Government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jpba.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T08:39:13Z","timestamp":1287131953000},"page":"646-652","source":"Crossref","is-referenced-by-count":43,"title":["Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines"],"prefix":"10.1016","volume":"54","author":[{"given":"Manal S.","family":"Elmasry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian S.","family":"Blagbrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf Aboul","family":"Kheir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2010.10.002_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00002512-199202020-00004","article-title":"Compliance aids \u2013 do they work?","volume":"2","author":"Rivers","year":"1992","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jpba.2010.10.002_bib0010","first-page":"784","article-title":"How are multi-compartment compliance aids used in primary care?","volume":"267","author":"Nunney","year":"2001","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2010.10.002_bib0015","unstructured":"Drug Safety Update 1 (2008) 8."},{"key":"10.1016\/j.jpba.2010.10.002_bib0020","first-page":"124","article-title":"Stability of medicinal products in compliance devices","volume":"248","author":"Walker","year":"1992","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2010.10.002_bib0025","first-page":"99","article-title":"Dealing with dosage aids","volume":"248","year":"1992","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2010.10.002_bib0030","first-page":"174","article-title":"Stability of medicines dispensed in compliance devices","volume":"248","year":"1992","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2010.10.002_bib0035","first-page":"75","article-title":"How stable are medicines moved from original packs into compliance aids?","volume":"276","author":"Church","year":"2006","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2010.10.002_bib0040","first-page":"85","article-title":"Blister-strip warning","volume":"256","year":"1996","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2010.10.002_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/j.2055-2335.2006.tb00881.x","article-title":"Stability implications of repackaging paracetamol tablets into dose administration aids","volume":"36","author":"Haywood","year":"2006","journal-title":"J. Pharm. Pract. Res."},{"key":"10.1016\/j.jpba.2010.10.002_bib0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/j.2055-2335.2007.tb00738.x","article-title":"Stability of frusemide tablets repackaged in dose administration aids","volume":"37","author":"Bowen","year":"2007","journal-title":"J. Pharm. Pract. Res."},{"key":"10.1016\/j.jpba.2010.10.002_bib0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0731-7085(99)00176-4","article-title":"Application of first-derivative UV spectrophotometry, TLC-densitometry and liquid chromatography for the simultaneous determination of mebeverine hydrochloride and sulpiride","volume":"21","author":"El Walily","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02466322","article-title":"Quantitative analysis of mebeverine in dosage forms by HPLC","volume":"44","author":"Al-Deeb","year":"1997","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2010.10.002_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bmc.556","article-title":"A validated chiral HPLC method for the determination of mebeverine HCl enantiomers in pharmaceutical dosage forms and spiked rat plasma","volume":"20","author":"Radwan","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2010.10.002_bib0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.chroma.2007.03.105","article-title":"Simultaneous determination of various pharmaceutical compounds in water by solid-phase extraction-liquid chromatography\u2013tandem mass spectrometry","volume":"1154","author":"Zhang","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2010.10.002_bib0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02262709","article-title":"Stability study and quantitative determination of mebeverine hydrochloride in tablets by means of reversed-phase high-performance liquid chromatography","volume":"20","author":"De Schutter","year":"1985","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2010.10.002_bib0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0731-7085(95)01608-2","article-title":"Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection","volume":"14","author":"Palumbo","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0731-7085(99)00292-7","article-title":"Validation of a LC method for the determination of 5-aminosalicylic acid and its metabolite in plasma and urine","volume":"22","author":"Bystrowska","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0090","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jpba.2004.03.016","article-title":"LC\u2013MS\/MS and FT-IR analyses of stones from a patient with Crohn's disease: a case report","volume":"35","author":"Orioli","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/bmc.456","article-title":"A validated HPLC method with electrochemical detection for simultaneous assay of 5-aminosalicylic acid and its metabolite in human plasma","volume":"19","author":"Palumbo","year":"2005","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2010.10.002_bib0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jchromb.2008.07.026","article-title":"Development and validation of a HPLC\u2013ESI-MS\/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma","volume":"872","author":"Pastorini","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2010.10.002_bib0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0378-4347(00)80666-0","article-title":"Stability of 5-aminosalicylic acid and 5-acetylaminosalicylic acid in plasma","volume":"432","author":"Brendel","year":"1988","journal-title":"J. Chromatogr. Biomed. Appl."},{"key":"10.1016\/j.jpba.2010.10.002_bib0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0378-4347(91)80205-Q","article-title":"High-performance liquid-chromatographic assay of 5-aminosalicylic acid (5-ASA) and its metabolites N-\u03b2-d-glucopyranosyl-5-ASA, N-acetyl-5-ASA, N-formyl-5-ASA and N-butyryl-5-ASA in biological fluids","volume":"570","author":"Tjornelund","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2010.10.002_bib0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jaoac\/68.4.803","article-title":"Liquid-chromatographic determination of sulphasalazine in tablets and bulk powder","volume":"68","author":"Egli","year":"1985","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jpba.2010.10.002_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0731-7085(88)80035-9","article-title":"Modified reversed-phase high-performance liquid-chromatographic method for the determination of plasma sulphasalazine concentrations","volume":"6","author":"Astbury","year":"1988","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0125","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0731-7085(91)80122-P","article-title":"Simultaneous determination of acetylsalicylic, salicylic, ascorbic and dehydroascorbic acid by HPLC","volume":"10","author":"Kmetec","year":"1992","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0731-7085(96)01813-4","article-title":"Development and validation of a reversed-phase liquid chromatographic method for analysis of aspirin and warfarin in a combination tablet formulation","volume":"15","author":"Montgomery","year":"1996","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0731-7085(00)00488-X","article-title":"LC method for the analysis of acetylsalicylic acid, caffeine and codeine phosphate in pharmaceutical preparations","volume":"25","author":"Altun","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0731-7085(01)00448-4","article-title":"A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine","volume":"26","author":"Abu-Qare","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0145","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0731-7085(03)00248-6","article-title":"Simultaneous determination of aspirin and isosorbide 5-mononitrate in formulation by reversed phase high pressure liquid chromatography","volume":"32","author":"Gandhimathi","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2010.10.002_bib0150","unstructured":"British Pharmacopoeia, The Stationery Office, London, 2008, pp. 192\u2013193, 1382, 1403\u20131405, 2060\u20132062."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708510005789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708510005789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T23:31:52Z","timestamp":1592004712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708510005789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0731708510005789"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2010.10.002","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}